.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Deloitte
Julphar
Federal Trade Commission
Fuji
Medtronic
Teva
Cipla
Healthtrust
Accenture

Generated: January 22, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: eprosartan mesylate

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Mylan Pharms IncEPROSARTAN MESYLATEeprosartan mesylateTABLET;ORAL202012ANDAMylan Pharmaceuticals Inc.0378-6629-9330 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-6629-93)
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Merck
Mallinckrodt
Daiichi Sankyo
US Department of Justice
Cipla
Harvard Business School
Cerilliant
Citi
Johnson and Johnson
Dow

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot